International Centre for Diarrheal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Incepta Pharmaceuticals Ltd., Dhaka, Bangladesh.
PLoS Negl Trop Dis. 2019 Jan 31;13(1):e0007124. doi: 10.1371/journal.pntd.0007124. eCollection 2019 Jan.
Cholera remains a substantial health burden in Asia and Africa particularly in resource poor settings. The standard procedures to identify the etiological organism V. cholerae are isolation from microbiological culture from stool as well as Polymerase Chain Reaction (PCR). Both the processes are highly lab oriented, labor extensive, time consuming, and expensive. In an effort to control for outbreaks and epidemics; an effective, convenient, quick and relatively less expensive detection method is imperative, without compromising the sensitivity and specificity that exists at present. The objective of this component of the study was to evaluate the effectiveness of a locally produced rapid diagnostic test (RDT) for cholera diagnosis.
In Bangladesh, nationwide cholera surveillance is ongoing in 22 hospitals covering all 8 divisions of the country since June, 2016. In the surveillance, stool samples have been collected from patients presenting to hospitals with acute watery diarrhea. Crystal VCTM (Span diagnostics, India) and Cholkit (locally produced RDT) have been used to detect V. cholerae from stool samples. Samples have also been sent to the main laboratory at icddr,b where the culture based isolation is routinely performed. All the tests were carried out for both direct and enriched stool samples. RDT sensitivity and specificity were calculated using stool culture as the gold standard.
A total of 7720 samples were tested. Among these, 5865 samples were solely tested with Crystal VC and 1355 samples with Cholkit whereas 381 samples were tested with both the RDTs. In comparison with culture, direct testing with Crystal VC showed a sensitivity of 72% (95% CI: 50.6% to 87.9%) and specificity of 86.8% (95% CI: 82.8% to 90.1%). After enrichment the sensitivity and specificity was 68% (95% CI: 46.5% to 85.1%) and 97.5% (95% CI: 95.3% to 98.8%) respectively. The direct Cholkit test showed sensitivity of 76% (95% CI: 54.9% to 90.6%) and specificity of 90.2% (95% CI: 86.6% to 93.1%).
This evaluation has demonstrated that the sensitivity and specificity of Cholkit is similar to the commercially available test, Crystal VC when used in field settings for detecting V. cholerae from stool specimens. The findings from this study suggest that the Cholkit could be a possible alternative for cholera endemic regions where V. cholerae O1 is the major causative organism causing cholera.
霍乱在亚洲和非洲仍然是一个严重的健康负担,特别是在资源匮乏的地区。鉴定病原体霍乱弧菌的标准程序是从粪便中进行微生物培养分离以及聚合酶链反应(PCR)。这两个过程都高度依赖实验室,劳动强度大,耗时且昂贵。为了控制疫情爆发和流行,必须有一种有效、方便、快速且相对便宜的检测方法,同时不影响目前存在的敏感性和特异性。本研究的这一部分的目的是评估一种本地生产的快速诊断检测(RDT)在霍乱诊断中的效果。
在孟加拉国,自 2016 年 6 月以来,全国性的霍乱监测在全国 22 家医院进行,覆盖该国所有 8 个地区。在监测中,从医院急性水样腹泻患者采集粪便样本。Crystal VCTM(印度 Span 诊断公司)和 Cholkit(本地生产的 RDT)用于从粪便样本中检测霍乱弧菌。样本还被送到 icddr,b 的主要实验室,那里常规进行基于培养的分离。所有测试均对直接和富集的粪便样本进行。使用粪便培养作为金标准,计算 RDT 的敏感性和特异性。
共检测了 7720 个样本。其中,5865 个样本仅用 Crystal VC 进行检测,1355 个样本用 Cholkit 进行检测,381 个样本用两种 RDT 进行检测。与培养相比,直接用 Crystal VC 检测的敏感性为 72%(95%CI:50.6%至 87.9%),特异性为 86.8%(95%CI:82.8%至 90.1%)。富集后,敏感性和特异性分别为 68%(95%CI:46.5%至 85.1%)和 97.5%(95%CI:95.3%至 98.8%)。直接 Cholkit 测试的敏感性为 76%(95%CI:54.9%至 90.6%),特异性为 90.2%(95%CI:86.6%至 93.1%)。
这项评估表明,Cholkit 的敏感性和特异性与商业上可获得的测试 Crystal VC 相似,可用于现场检测粪便标本中的霍乱弧菌。本研究的结果表明,Cholkit 可能是霍乱流行地区的一种替代方法,因为霍乱弧菌 O1 是引起霍乱的主要病原体。